High progesterone levels associated with pregnancy or injectable contraception can double risk for acquiring and transmitting HIV infection.
Having high levels of progesterone (such as those seen during pregnancy and with use of depot medroxyprogesterone acetate [DMPA]) might raise women's risk for acquiring and transmitting HIV infection, but data have been inconsistent. To further evaluate this possibility, investigators conducted two secondary analyses of data collected prospectively from >3300 HIV-serodiscordant couples in Africa. In about 65% of couples, the woman was the infected partner. Median follow-up was 18 to 20 months.
HIV incidence in male partners of infected women doubled when their partners were pregnant versus not pregnant (adjusted hazard ratio, 2.5; 95% confidence interval, 1.3–4.8). HIV incidence in women was 7.4 versus 3.0 per 100 person-years during pregnan…
Reviewing Author
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine
DisclosuresConsultant/Advisory BoardPlanned Parenthood Federation of America
Grant/Research SupportSociety of Family Planning; California Department of Public Health Tobacco Control Program
Editorial BoardsContraception; Journal of General Internal Medicine
Leadership Positions in Professional SocietiesCouncil Member, Society of General Internal Medicine